Cortisol suppression after administration of a combination of an H1-receptor antagonist and a corticosteroid. Quantification of the pharmacodynamic effect
Ganote, D.P.; von Hattingberg, H.M.; Hennings, G.; Rehn, D.; Lücker, P.W.
Arzneimittel-Forschung 33(3): 432-436
1983
ISSN/ISBN: 0004-4172 PMID: 6135429 Document Number: 217756
Document emailed within 1 workday
Related Documents
Knick, B. 1976: Antibiotic therapy in combination with pharmacodynamic dosage of corticosteroid derivatives Die Medizinische Welt 27(35): 1635-1637Ordian, N.E.; Pivina, S.G. 1999: Changes in binding of corticosteroid receptors in the rat brain after cortisol administration during prenatal ontogenesis Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 85(5): 690-695
Breithaupt-Grögler, K.; Malerczyk, C.; Belz, G.G.; Butzer, R.; Herrmann, V.; Stass, H.; Wensing, G. 1997: Pharmacodynamic and pharmacokinetic properties of an angiotensin Ii receptor antagonist--characterization by use of Schild regression technique in man International Journal of Clinical Pharmacology and Therapeutics 35(10): 434-441
Dubourdieu, S.; Charbonnel, B.; Massai, M.R.; Marraoui, J.; Spitz, I.; Bouchard, P. 1991: Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration Fertility and Sterility 56(3): 440-445
Dammann, H.G.; Gottlieb, W.R.; Walter, T.A.; Dreyer, M.; Müller, P.; Simon, B.; Keohane, P. 1986: Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine Hepato-Gastroenterology 33(5): 217-220
Yamada, S.; Matsuoka, Y.; Kato, Y.; Kimura, R.; Inagaki, O. 1992: A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 262(2): 589-594
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913
Miyahara, Y.; Miyazaki, T.; Tanaka, Y.; Uchida, K.; Tamura, T.; Masuda, N.; Yamashita, S.; Yonei, A. 2004: A case of intraoperative hyperkalemia induced with administration of an angiotensin II receptor antagonist (AIIA) and intake of dried persimmons Masui. Japanese Journal of Anesthesiology 53(5): 543-546
Houdeshell, J.W. 1970: The effect of a corticosteroid combination on blood and synovial fluid in horses Veterinary Medicine-Small Animal Clinician 65(10): 963-966
Mukai, M.; Ando, K.; Koike, S.; Ishikawa, T.; Ryu, M.; Nagashima, T.; Nagao, K.; Isono, K. 1986: Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 1): 556-562
Aoyama, N. 2007: Effect of combination therapy with angiotensin Ii type i receptor and aldosterone receptor blockers in heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 145-149
Periclou, A.P.; Nandy, P.; Avramis, V.I. 2000: Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT) In Vivo 14(3): 377-388
Pill, J.; Wolf, O.; Schmelz, A.; Stegmeier, K.; Metz, J. 1990: Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban Zeitschrift für Kardiologie 79(Suppl 3): 155-160
Venitz, J.; Lücker, P.W.; Niehaus, H. 1984: Effect of a betamethasone-dimethidine-maleate combination on dermatologic diseases. Determination of plasma cortisol levels before, during and after several days' therapy Fortschritte der Medizin 102(35): 882-884
Castello, D.; Bignante, T.; Griffa Goia, A.M. 1975: Effect of the circadian rhythm on corticosteroid administration in the treatment of juvenile asthma. Primary results Minerva Pediatrica 27(35): 1981-1984
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Ennis, C.; Cox, B. 1980: The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors Journal of Pharmacy and Pharmacology 32(6): 434-435
Barbezat, G.O.; Bank, S. 1976: Effect of a histamine H2-receptor antagonist and an anticholinergic on gastric acid secretion in man South African Medical Journal 50(22): 849-851
Krausz, M.M.; Dahan, J.B.; Gross, D. 1988: Effect of the leukotriene receptor antagonist LY-171883 on endotoxemia in awake sheep Circulatory Shock 26(4): 431-441
Debeljuk, L.; Bandera, R.; Bartke, A. 1997: Effect of a non-peptide NK-2 tachykinin receptor antagonist on LH, FSH, and prolactin release by rat hemipituitaries in vitro Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 48(3): 461-478